Press release
Postoperative Acute Pain Market is projected to reach USD 18.92 billion by 2034
Postoperative Acute Pain
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70919
Postoperative acute pain occurs in the hours to days following surgery and varies depending on procedure type, surgical technique, and patient comorbidities. Effective post-surgical pain control is essential to enhance recovery, reduce complications, shorten hospital stays, and support early mobilization - all core components of Enhanced Recovery After Surgery (ERAS) protocols.
Key Market Highlights
• 2024 Market Size: USD 12.84 billion
• 2034 Forecast: USD 18.92 billion
• CAGR (2025-2034): 4.0%
• Largest Segment: Non-opioid analgesics
• Fastest-Growing Segment: Long-acting local anesthetics & novel non-opioid injectables
Epidemiology & Clinical Insights
1. Rising Surgical Volumes
Over 330 million surgeries are performed globally each year, including:
• Orthopedic
• General surgery
• Cardiothoracic
• Obstetrics & gynecology
• Gastrointestinal
• Neurosurgery
More surgeries = higher demand for post-operative analgesics.
2. Pain Severity & Duration
• Acute pain typically lasts hours to 72 hours post-surgery
• Up to 80% of patients experience moderate to severe pain
• Poorly managed postoperative pain increases risk of chronic pain development
3. ERAS Influence
Enhanced Recovery After Surgery guidelines strongly encourage:
• Multimodal analgesia
• Opioid sparing
• Early mobilization
Market Growth Drivers
1. Shift Toward Opioid-Sparing Protocols
Regulatory pressure and safety concerns drive adoption of:
• NSAIDs
• Acetaminophen
• COX-2 inhibitors
• Long-acting local anesthetics
2. Innovation in Local & Regional Anesthesia
Advancements include:
• Liposomal bupivacaine
• Extended-release nerve block formulations
• Continuous nerve catheters
These enable prolonged pain relief without systemic opioid use.
3. Growth of Outpatient & Same-Day Surgery
Ambulatory surgery centers rely heavily on fast-acting, safe analgesics.
4. Increasing Use of Multimodal Analgesia
Combining different drug classes improves pain control and reduces opioid doses.
5. Rising Geriatric Surgical Population
Older adults often require orthopedic, cardiac, and abdominal surgeries.
Market Restraints
• Adverse effects of opioid and non-opioid analgesics
• Reimbursement constraints for newer injectables
• Variability in ERAS adoption across regions
• Risks of chronic opioid use after surgery
Market Opportunities
1. Novel Non-Opioid Injectables
TRPV1 modulators, NOP receptor agonists, and sodium-channel blockers.
2. Extended-Release Local Anesthetics
Longer-duration pain relief reduces need for opioids and inpatient monitoring.
3. AI-Driven Personalized Pain Management
Predicts pain scores and tailors drug selection.
4. Digital Health & Wearable Monitoring
Post-surgery pain monitoring at home.
5. Robotic & Minimally Invasive Surgery
Reduces overall pain but increases demand for optimized fast-recovery analgesics.
Segmentation Overview
By Drug Class
• Non-opioids: NSAIDs, acetaminophen, COX-2 inhibitors
• Opioids: morphine, hydromorphone, fentanyl
• Local anesthetics: bupivacaine, ropivacaine, lidocaine
• Combination analgesics
• Emerging therapies
By Route of Administration
• Oral
• IV
• Intramuscular
• Epidural
• Peripheral nerve block
• Topical / transdermal
By Surgery Type
• Orthopedic
• General surgery
• Cardiovascular
• Obstetrics & gynecology
• Gastrointestinal
• Urologic
• Others
By End User
• Hospitals
• Ambulatory surgery centers
• Specialty surgical clinics
• Retail & online pharmacies
Explore Full Report here: https://exactitudeconsultancy.com/reports/70919/postoperative-acute-pain-market
Regional Insights
North America - Largest Market
High surgical volumes, strong ERAS adoption, and rapid uptake of long-acting anesthetics.
Europe - Strong Multimodal Analgesia Adoption
Germany, UK, France, Italy, and Spain lead usage of NSAIDs and combination therapy.
Asia Pacific - Fastest Growing
Expanding healthcare access, increased elective surgeries, and rising pharmaceutical investment.
Latin America - Developing
Growth driven by improving surgical infrastructure in Brazil, Mexico, and Argentina.
Middle East & Africa - Emerging
Increasing government investment in surgical care and postoperative recovery.
Competitive Landscape
Major companies in the postoperative acute pain market include:
• Pfizer
• Johnson & Johnson
• Teva Pharmaceuticals
• Eli Lilly
• Grunenthal
• Pacira BioSciences (liposomal bupivacaine)
• Fresenius Kabi
• Mylan / Viatris
• Bayer
• Novartis
R&D focuses on opioid-sparing analgesics, sustained-release anesthetics, and multimodal pain therapy optimization.
Recent Market Developments
• Growing global adoption of liposomal bupivacaine in orthopedic and soft-tissue surgeries
• FDA approvals for new non-opioid injectable pain medications
• Integration of nerve-block technologies in ERAS pathways
• AI-driven postoperative pain prediction models in pilot use
• Launch of fast-acting intranasal analgesics for ER settings
Future Outlook (2025-2034)
The Postoperative Acute Pain Market will expand as:
• Non-opioid and multimodal analgesia becomes the global standard of care
• Advanced local anesthetic delivery reduces opioid dependence
• Minimally invasive surgery increases demand for rapid-recovery pain control
• Technological innovations improve personalization and monitoring
By 2034, the market is expected to reach USD 18.92 billion, driven by global surgical volume growth and continuous innovation in postoperative pain management.
This report is also available in the following languages : Japanese (術後急性疼痛), Korean (수술 후 급성 통증), Chinese (术后急性疼痛), French (Douleur aiguë postopératoire), German (Postoperativer akuter Schmerz), and Italian (Dolore acuto postoperatorio), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/70919
Our More Reports:
Moderate To Severe Acute Pain Market
https://exactitudeconsultancy.com/reports/70916/moderate-to-severe-acute-pain-market
Non-Postoperative Acute Pain Market
https://exactitudeconsultancy.com/reports/70917/non-postoperative-acute-pain-market
Acute Pain Market
https://exactitudeconsultancy.com/reports/70981/acute-pain-market
Lumbosacral Radicular Pain Market
https://exactitudeconsultancy.com/reports/71947/lumbosacral-radicular-pain-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Postoperative Acute Pain Market is projected to reach USD 18.92 billion by 2034 here
News-ID: 4311494 • Views: …
More Releases from Exactitude Consultancy
Urea Cycle Disorders (UCD) Market is expected to reach USD 3.42 billion by 2034
The global Urea Cycle Disorders (UCD) Market was valued at USD 1.86 billion in 2024 and is expected to reach USD 3.42 billion by 2034, growing at a CAGR of 6.3% during 2025-2034. Growth is driven by increasing newborn screening adoption, rising clinical recognition of hyperammonemia symptoms, advancements in ammonia-scavenging therapeutics, and ongoing development of gene and mRNA-based therapies targeting specific enzyme defects.
Download Full PDF Sample Copy of Market Report…
Diamond-Blackfan Anemia (DBA) Market Growing at a CAGR of around 7.1%
Diamond-Blackfan Anemia (DBA) Market
The Diamond-Blackfan Anemia (DBA) Market was valued at ~USD 210 million in 2024 and is projected to reach ~USD 420 million by 2034, growing at a CAGR of around 7.1%. Growth is driven by expanding diagnosis of inherited bone marrow failure syndromes, increasing use of corticosteroid therapy, and rising interest in gene-based treatments.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71277
Key Market Drivers
• Better identification of ribosomal…
Non-Postoperative Acute Pain Market is projected to reach USD 29.76 billion by 2 …
The global Non-Postoperative Acute Pain Market was valued at USD 19.84 billion in 2024 and is projected to reach USD 29.76 billion by 2034, growing at a CAGR of 4.1% during 2025-2034. Growth is driven by rising incidence of trauma, musculoskeletal injuries, dental procedures, acute infections, and chronic disease flare-ups that require short-term pain control. Increasing emergency room visits, expanding geriatric populations, and innovations in non-opioid analgesics are also shaping…
Inflammation and Pain Post-Cataract Surgery Market is projected to reach USD 3.9 …
The global Inflammation and Pain Post-Cataract Surgery Market was valued at USD 2.34 billion in 2024 and is projected to reach USD 3.91 billion by 2034, growing at a CAGR of 5.3% during 2025-2034. Growth is driven by increasing cataract surgery volumes worldwide, broader adoption of premium intraocular lenses (IOLs), rising elderly populations, and growing preference for advanced ophthalmic anti-inflammatory and analgesic therapies that improve surgical outcomes.
Download Full PDF Sample…
More Releases for Pain
Comprehensive Pain Management Services Expanded by Denver Pain Management Clinic
Image: https://www.globalnewslines.com/uploads/2025/01/1737464973.jpg
Denver Pain Management Clinic announces expanded services for individuals suffering from chronic pain conditions throughout the Denver metropolitan area. The clinic, established in 2010, continues to strengthen its position as a leading provider of comprehensive pain management services in Colorado through its team of specialized Denver Pain Doctors.
DENVER, CO - October 9, 2025 - Denver Pain Management Clinic [https://denverpainmanagementclinic.com/] announces expanded services for individuals suffering from chronic pain conditions…
Enhanced Pain Relief Solutions at Advanced Pain Care
Image: https://www.globalnewslines.com/uploads/2025/03/3f3b6259bfdec02e5dcb7b9d0c838855.jpg
Advanced Pain Care is helping people who suffer from chronic pain with sophisticated, evidence-based treatments. The clinic is particularly focused on non-surgical care that improves the quality of life. With a team of highly qualified pain experts, they work with patients who have back pain, joint pain, and nerve pain.
Personalized Treatment for Every Pain Disorder
Advanced Pain Care offers treatments depending on the cause of pain. Anyone experiencing arthritis, migraine,…
Pain Finisher | Advanced Pain Relief Device
Pain Finisher is an instant pain relief device that is effective on all pains including back pain and knee pain. It is based on the TENS theory of pain management which is easy to use and safe.
By using Pain Finisher, a modern drug-free and non-invasive pain-relieving treatment method, one can get rid of the common pain creams, gels, and risky treatment methods.
So, have a pain-free life with easy-to-use pain relief…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Visceral Pain Market Analysis 2024: Addressing Pain Management Challenges
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033.
The Business Research Company presents an extensive market research report on the Visceral Pain Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,…
Global Post-Operative Pain Management Market: Pain Relief Goes Worldwide
Introduction:
The Global Post-Operative Pain Management Market is growing at a rapid pace. This market involves the management of pain after surgical procedures. The market has witnessed significant growth in recent years, owing to the increasing number of surgeries and the rising prevalence of chronic diseases. Pain management is an essential aspect of healthcare, as uncontrolled pain can lead to prolonged hospital stays, delayed recovery, and poor patient outcomes.
In this article,…
